Company Virbac

VIRP

FR0000031577

Pharmaceuticals

Real-time Euronext Paris Other stock markets 05:55:16 2025-06-17 am EDT			5-day change	1st Jan Change
314.50 ^EUR	-0.16%		-3.53%	-0.63%

Apr. 16	VIRBAC : Decent Q1; Clarity on US tariff exposure was a key takeaway
Apr. 16	VIRBAC : Stifel still buying after Q1 results	CF

Business description: Virbac

Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows:

- pet medications (61.6%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips;

- livestock medications (38.4%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc.

Net sales are distributed geographically as follows: Europe (40.8%), Latin America (15.9%), North America (13%), India/Africa/Middle East (12.5%), East Asia (10.1%) and Pacific (7.7%).

Number of employees: 6,365

Sales by Activity: Virbac

Fiscal Period: December	2020	2021	2022	2023	2024
Companion Animals	-	609M	706M	721M	824M
Farm Animals	-	426M	478M	493M	537M
Other Businesses	-	28.8M	31.8M	33.2M	36.3M

See all business segments

Geographical breakdown of sales: Virbac

Fiscal Period: December	2020	2021	2022	2023	2024
Europe	-	-	-	-	571M
Latin America	149M	167M	197M	214M	222M
North America	121M	124M	162M	165M	182M
India, Africa and Middle East ("IMEA")	-	-	-	-	174M
Far East Asia	-	-	-	-	141M
Pacific	80.67M	94.19M	118M	116M	108M
Africa & Middle East	25.54M	29.7M	32.47M	29.67M	-
Europe (Excluding france)	248M	281M	303M	327M	-
Asia	162M	184M	213M	204M	-
France	148M	185M	192M	192M	-

See all geographic segments

Executive Committee: Virbac

Manager	Title	Age	Since
Habib Ramdani CEO	Chief Executive Officer	49	2024-09-26
Sophie Favini COO	Chief Operating Officer	-	2023-06-30
Bertrand Havrileck CTO	Chief Tech/Sci/R&D Officer	-	2020-12-31
Michel Garaudet DFI	Director of Finance/CFO	70	2010-07-26
Marc Bistuer PRN	Corporate Officer/Principal	64	2020-12-14

See VIRBAC governance

Composition of the Board of Directors: Virbac

Director	Title	Age	Since
Marie-Hélène Dick-Madelpuech CHM	Chairman	60	2006-03-31
Philippe Capron BRD	Director/Board Member	66	2010-07-27
Pierre Madelpuech BRD	Director/Board Member	64	2017-09-04
Solène Madelpuech BRD	Director/Board Member	31	2017-09-04
Sylvie Gueguen BRD	Director/Board Member	60	2018-10-29
Cyrille Yann Nicolas Petit BRD	Director/Board Member	55	2019-06-17

Composition of the Board of Directors

Shareholders: Virbac

Name	Equities	%	Valuation
Dick Family 50.09 %	4,203,226	50.09 %	1 589 M €
Financière de l'Échiquier SA 1.604 %	134,570	1.604 %	51 M €
Amundi Asset Management SASU (Investment Management) 0.762 %	63,938	0.762 %	24 M €
BNP Paribas Asset Management Belgium SA 0.7176 %	60,208	0.7176 %	23 M €
Société Virbac SA Employee Stock Ownership Plan 0.5724 %	48,029	0.5724 %	18 M €

List of VIRBAC shareholders

Holdings: Virbac

Name	Equities	%	Valuation
VIRBAC 0.19%	16,066	0.19%	6,073,563 $

Company details: Virbac

Virbac SA

13e rue LID

06511, Carros

+33 4 92 08 71 00

http://www.virbac.fr

Group companies: Virbac

Name	Category and Sector
Virbac Nutrition SAS Virbac Nutrition SAS Food: Specialty/CandyConsumer Non-Durables Part of Virbac SA, Virbac Nutrition SAS is a French company that manufactures and wholesales pet food. The company is based in Vauvert, France. The company was founded in 1987. Philippe Domptail has been the CEO of the company since 2011.	Food: Specialty/Candy
Bio Veto Tests SA Bio Veto Tests SA Pharmaceuticals: MajorHealth Technology Part of Virbac SA, Virbac Diagnostics SAS is a French company that develops vaccines against viral and parasitic diseases in companion animals. The company is based in Sanary sur Mer, France. Bruno ROY has been the CEO of the company since 2006. Virbac Diagnostics was acquired by Virbac SA on May 07, 2003.	Pharmaceuticals: Major
Virbac RSA (Pty) Ltd.	Pharmaceuticals: Major
Virbac Animal Health India Pvt Ltd.	Miscellaneous Commercial Services
Globion India Pvt Ltd. Globion India Pvt Ltd. BiotechnologyHealth Technology Globion India Pvt Ltd. is a private company that engages in the development, manufacturing, and commercialization of live and inactivated vaccines. The company is based in Secunderabad, India. It was founded in 2006, and the CEO is V. K. Shankar.	Biotechnology

See all subsidiaries

Veterinary Drugs

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
VIRBAC	-0.48%	-3.83%	-8.06%	-6.14%	3.06B
ZOETIS INC.	+0.03%	-3.40%	-3.62%	+3.99%	73.18B
ELANCO ANIMAL HEALTH INCORPORATED	+1.30%	+0.65%	-22.41%	-33.13%	6.95B
BLUESTAR ADISSEO COMPANY	0.00%	+0.21%	-1.03%	-3.70%	3.6B
VIMIAN GROUP AB	-2.08%	-9.79%	+18.50%	-10.24%	2.23B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	-0.98%	-4.28%	+40.15%	+20.38%	1.28B
WUHAN KEQIAN BIOLOGY CO.,LTD	-2.83%	-7.06%	0.00%	-36.03%	1.02B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	+1.16%	+0.86%	-14.32%	-43.82%	996M
PHIBRO ANIMAL HEALTH CORPORATION	+3.26%	+2.62%	+43.50%	+35.25%	1B
VETOQUINOL SA	-1.00%	-7.10%	-28.78%	-37.34%	957M
Average	-0.29%	-2.76%	+2.39%	-11.08%	9.43B
Weighted average by Cap.	-0.05%	-0.55%	-3.76%	-0.51%